John Bass, PA
Physician Assistant · Goldsboro, NCNPI 1336288091
Payments from drug & device makers
Across 192 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$533
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$485
- Novo Nordisk$483
- Amgen$254
- Preventric Diagnostics, Inc.$200
- Irhythm Technologies, Inc.$153
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,984100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $533 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 30 | $485 |
| Novo Nordisk | 24 | $483 |
| Amgen(2 entities) | 18 | $254 |
| Preventric Diagnostics, Inc. | 1 | $200 |
| Irhythm Technologies, Inc. | 5 | $153 |
| Boehringer Ingelheim | 9 | $146 |
| GSK | 11 | $139 |
| Neurocrine Biosciences, Inc. | 1 | $137 |
| Merck | 8 | $125 |
| Bayer | 1 | $114 |
| Lilly USA, LLC | 7 | $114 |
| Pfizer | 6 | $103 |
| Johnson & Johnson(2 entities) | 6 | $95 |
| Sanofi Pasteur Inc. | 2 | $93 |
| Abbott | 4 | $87 |
| Amarin Pharma, Inc. | 5 | $84 |
| Sanofi | 2 | $82 |
| AstraZeneca | 2 | $76 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $71 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| Mylan Specialty L.p. | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Exact Sciences | 2 | $36 |
| Dexcom, Inc. | 2 | $33 |
| Eisai Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Angiodynamics, Inc. | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $23 |
| Medicomp Inc | 1 | $16 |
| Novartis | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,984 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 137 | $118,494 |
| TrulicityDulaglutide | 48 | $61,650 |
| JardianceEmpagliflozin | 77 | $60,885 |
| OzempicSemaglutide | 39 | $46,442 |
| LinzessLinaclotide | 21 | $24,666 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $21,797 |
| JanuviaSitagliptin Phosphate | 23 | $21,014 |
| MounjaroTirzepatide | 16 | $16,390 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $7,574 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 32 | $5,247 |
| Atorvastatin Calcium | 269 | $2,828 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 78 | $2,792 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,448 |
| Gabapentin | 108 | $2,230 |
| Potassium Chloride | 87 | $1,894 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $103 | $118,494137 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $114 | $78,04064 claims |
| Boehringer IngelheimJardiance | $146 | $60,88577 claims |
| Novo NordiskOzempic | $483 | $46,44239 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $139 | $29,37150 claims |
| AbbVieLinzess, Synthroid | $533 | $25,68433 claims |
| MerckJanuvia | $125 | $21,01423 claims |
| AstraZenecaSymbicort | $76 | $2,44811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Goldsboro
- Brooke JonesGoldsboro$259K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.